Cindolo et al developed a model for predicting the risk of tumor recurrence in a patient with nonmetastatic renal cell carcinoma. The authors are from the University Federico II in Naples, CHU Henri Mondor in Creteil (France), and the CHU Pontchaillou in Rennes (France).
NOTE: The score uses the same parameters as the model of Yaycioglu et al (above).
Patient selection: nonmetastatic renal cell carcinoma who underwent a nephrectomy
Parameters:
(1) clinical symptom status at diagnosis
(2) maximum diameter of the tumor
Clinical symptoms included:
(1) acute flank pain
(2) lumbar pain
(3) palpable mass
(4) hematuria
(5) anemia
(6) weight loss
(7) asthenia
(8) hypercalcemia
Clinical Symptoms |
Points |
absent |
0 |
any present |
1 |
recurrence risk formula =
= (1.28 * (points for symptom status)) + (0.13 * (maximum diameter in cm))
Interpretation:
• The minimum score is probably around 0.01.
• The maximum score is probably around 3.0.
• A score > 1.2 was considered high risk for recurrence.
• To get a high risk score, either the patient is symptomatic at presentation or the tumor measures > 9.2 cm.
Score |
Risk Group |
Risk of Recurrence at 2 Years |
Risk of Recurrence at 5 Years |
<= 1.2 |
low |
0.96 |
0.93 |
> 1.2 |
high |
0.83 |
0.68 |
Specialty: Hematology Oncology, Surgery, general, Nephrology
ICD-10: ,